In hepatocellular carcinoma, MDK overexpression decreased the expression of programmed death ligand 1 (PD-L1) in MDSCs, promoting immunosuppression and reducing the cytotoxicity of T cells. The gene discussed is MDK; the disease is hepatocellular carcinoma.